Patent intelligence · US
US 12076377
Variant sulfatase enzymes with enhanced properties
Variant sulfatase enzymes with enhanced properties
Patent details — US 12076377
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 3, 2024
- Expiration
- Aug 29, 2044
- Claims
- 9
- CPC classes
- A61K, A61K38/16, A61K38/465
Quick answer
US 12076377 (Variant sulfatase enzymes with enhanced properties) is held by INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.. Status: granted. Granted Sep 3, 2024. Expires Aug 29, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K38/16, A61K38/465
More from INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
Related pharmaceutical patents in our USPTO index.
-
US 11421021
Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides
granted -
US 11260120
Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
granted -
US 11186626
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
granted -
US 11154614
Method for producing virus like particles
granted -
US 11135280
Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity
granted -
US 11028153
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted -
US 10653800
Oligonucleotide-based probes for detection of bacterial nucleases
granted
Frequently asked questions
What is US patent 12076377?
US 12076377 (Variant sulfatase enzymes with enhanced properties) is held by INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.. Status: granted. Granted Sep 3, 2024. Expires Aug 29, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12076377?
INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 42 pharmaceutical patents for this assignee.
When does US 12076377 expire?
Our index shows an expiration date of Aug 29, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.